LOPEZ GEORGE A

SEC source: 0001073397-19-000006 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,964

F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $184.00 to $184.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-19-000006 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,803

SEC source: 0001073397-19-000004 · edgardoc.xml · derivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2021-07-20

F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001073397-19-000004 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,864

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $184.63 to $185.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-19-000004 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,386

F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $183.63 to $184.62, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-19-000004 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 368,864

SEC source: 0001073397-19-000002 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,864

F1 · price: Shares transferred as a bona fide gift without any consideration.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,648

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.20 to 291.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,357

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $289.15 to 290.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367,680

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $288.10 to 289.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,497

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $287.05 to 288.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 8

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,444

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F9 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.08 to 292.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 7

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,310

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F8 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.05 to 292.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 6

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,905

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F7 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.00 to 290.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,953

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F6 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $288.95 to 289.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379,853

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $293.35 to 293.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,159

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.15 to 293.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 381,110

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.10 to 292.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 387,875

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.05 to 291.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 11

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 395,716

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F12 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.60 to $293.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 10

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 397,095

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F11 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.50 to $292.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 9

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 402,688

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F10 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.45 to $291.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 8

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,988

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F9 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.88 to $293.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 7

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405,813

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F8 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.85 to $292.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 6

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 410,782

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F7 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.80 to $291.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,116

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F6 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.65 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,216

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.15 to $296.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,416

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $293.85 to $294.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,385

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.75 to $293.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000010 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,016

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.70 to $292.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000012 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,648

F1 · price: Shares transferred as a bona fide gift without any consideration.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 18

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,716

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F12 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 17

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 428,816

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F18 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $257.15 to $258.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 16

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 432,739

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F17 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $256.10 to $257.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 15

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,839

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F16 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $255.10 to $256.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 14

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 439,523

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F15 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $253.95 to $254.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 13

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 440,379

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F14 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $252.80 to $253.40, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 12

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441,844

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F13 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $251.75 to $252.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 11

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,800

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F12 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 10

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,900

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F11 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $262.20 to $262.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 9

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F10 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $261.00 to $262.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 8

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 446,816

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F9 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $259.95 to $260.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 7

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 448,851

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F8 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $258.85 to $259.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 6

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 451,054

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F7 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $265.00 to $265.65, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 451,955

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F6 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $263.95 to $264.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,964

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $262.90 to $263.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 457,745

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $261.85 to $262.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 459,916

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $260.80 to $261.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000008 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461,416

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $259.25 to $259.60, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000006 · edgardoc.xml · nonDerivative · entry 6

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461,716

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.